Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow-Reference-Cited by-同舟云学术

Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow

Published:1993-07 Issue:7 Volume:17 Page:585-592
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Tanaka Masao

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. High dose cytarabine: a review;Bolwell;Leukemia,1988

2. Cytosine arabinoside;Chabner,1982

3. Studies of cellular proliferation in human leukemia. I. Estimation of growth rate of leukemia and normal hematopoietic cells in two adults with acute leukemia;Clarkson;J. clin. Invest.,1967

4. Sequential flow cytometric analysis of cellular DNA content in peripheral blood during treatment of acute leukemia;Aardal;Scand. J. clin. Invest.,1979

5. Discrimination of human leukemia subtypes by flow-cytometric analysis of cellular DNA and RNA;Andreff;Blood,1984

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease;Annals of Hematology;2023-05-05

2. Controversies Regarding Use of Myeloid Growth Factors in Leukemia;Journal of the National Comprehensive Cancer Network;2017-12

3. Effects of Priming with Recombinant Human Granulocyte Colony–Stimulating Factor on Conditioning Regimen for High-Risk Acute Myeloid Leukemia Patients Undergoing Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation: A Multicenter Randomized Controlled Study in Southwest China;Biology of Blood and Marrow Transplantation;2014-12

4. Use of rHuG-CSF for the Treatment of Myeloid Leukemia and in Targeting Leukemia Stem Cells;Twenty Years of G-CSF;2011-11-15

5. Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study;Cancer;2010-04-01